TAG:
management contract
Private Equity Firms: Ready to Buy More Labs?
By Robert Michel | From the Volume XII No. 16 – November 14, 2005 Issue
CEO SUMMARY: Times are good in the laboratory industry. At least that’s the opinion of a growing number of professional investors. They are searching throughout the country for laboratories to acquire. They are motivated by the consistent financial performance of many lab companies, bot…
New OIG Opinion 05-08 On Phlebotomy Fees
By Robert Michel | From the Volume XII No. 10 – July 11, 2005 Issue
CEO SUMMARY: At the request of a yet-unidentified laboratory, the Office of the Inspector General issued Advisory Opinion 05-08 last month. It is a negative opinion on a proposed arrangement where a laboratory would reimburse client physicians as much as $6 for each blood draw performed b…
RFID, Georgetown University Hospital, HIV Screening Studies, MDS, Duke, HCA, Cigna
By Robert Michel | From the Volume XII No. 3 – February 14, 2005 Issue
PFIZER AND GLAXO-SK TO USE RFID TAGS IN 2005, RFID TEST IN BLOOD BANK RADIO FREQUENCY IDENTIFICATION (RFID) is making swift progress in a variety of healthcare applications. The Food and Drug Administration (FDA) wants to secure the nation’s drug supply through widespread…
DIANON Systems, IMPATH, Specialty Labs, Dynacare, Quest, LabCorp
By Robert Michel | From the Volume VIII No. 3 – February 26, 2001 Issue
DIANON & IMPATH REPORT 2000 EARNINGS TWO OF THE NATIONAL anatomic pathology companies reported fourth quarter earnings. Both DIANON Systems, Inc. and IMPATH, Inc. posted big gains in revenues and operating profits for 2000. At DIANON Systems, revenues r…
Number of Hospital Deals Declines Again in 2000
By Robert Michel | From the Volume VIII No. 1 – January 15, 2001 Issue
CEO SUMMARY: Probably the single biggest contributing factor to consolidation of hospital laboratories is when new owners or new healthcare systems take control of a hospital. For 2000, merger and acquisition activity in the hospital industry declined in 2000 by 40%. A total of 318 hospit…
AmeriPath Will Acquire Inform DX for $44.6 Mil
By Robert Michel | From the Volume VII No. 16 – November 13, 2000 Issue
CEO SUMMARY: It’s another example of consolidation in the anatomic pathology marketplace. AmeriPath, Inc.’s acquisition of Inform DX, Inc. positions the company to do as much as $350 million in revenues next year. By acquiring Inform DX, AmeriPath also gains entry into six more states…
Pathology Profession Facing New Directions
By Robert Michel | From the Volume VII No. 2 – January 24, 2000 Issue
CEO SUMMARY: Big changes ahead during the next decade. Among the predictions: the number of two and three-pathologist group practices will radically diminish; pathology centers of excellence will achieve new market dominance; and…ever more intense competition for anatomic pathology spec…
PPM Giant MedPartners Exits Doctor Management
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
THIRD IN A SERIES WHAT DOES IT MEAN WHEN the largest companies in a multibillion dollar industry announce that they will “get out” of that business? That is the question which must be answered after MedPartners, Inc. joined PhyMatrix Corp. in p…
30-Hospital Lab Contract Inked By Tenet & SBCL
By Robert Michel | From the Volume V No. 1 – January 19, 1998 Issue
CEO SUMMARY: By signing this deal with Tenet, SmithKline Beecham Clinical Laboratories captured one of the largest hospital laboratory management contracts ever offered. The project’s size, scale and far-flung geography make this a daunting challenge, particularly given California’s c…
Consider Tenet-SBCL Deal As Timely Wake-Up Call
By Robert Michel | From the Volume V No. 1 – January 19, 1998 Issue
CEO SUMMARY: Expect the Tenet-SBCL contract announcement to trigger similar deals during the next 18 months. Competition and the need to gain economic advantage will drive some hospital CEOs to turn their laboratories over to commercial laboratory partners. The number of such joint ventur…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized